1. Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent
- Author
-
Mineo Kondo, Hisashi Matsubara, Ryohei Miyata, Kengo Ikesugi, Shunsuke Yasuda, Kumiko Kato, Shinji Ueno, Masahiko Sugimoto, and Hiroko Terasaki
- Subjects
Adult ,Male ,Vascular Endothelial Growth Factor A ,medicine.medical_specialty ,genetic structures ,Visual Acuity ,Photopsia ,Angiogenesis Inhibitors ,Retina ,Flicker Fusion ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Central retinal vein occlusion ,Ophthalmology ,Retinal Vein Occlusion ,Electroretinography ,Humans ,Medicine ,Fluorescein Angiography ,Dilated eyes ,Aged ,Retrospective Studies ,Aged, 80 and over ,Anti vegf ,medicine.diagnostic_test ,business.industry ,Flicker ,Retinal ,Middle Aged ,Prognosis ,medicine.disease ,eye diseases ,chemistry ,030221 ophthalmology & optometry ,Female ,sense organs ,medicine.symptom ,business ,Erg ,Tomography, Optical Coherence ,030217 neurology & neurosurgery - Abstract
Purpose To determine the clinical characteristics, prognosis, and effect of anti-vascular endothelial growth factor (VEGF) agents on eyes with a central retinal vein occlusion (CRVO) with and without supernormal flicker ERG amplitudes. Methods Forty-eight eyes of 48 patients with a CRVO were studied. Flicker ERGs were recorded from fully dilated eyes with the RETeval system. The amplitudes and implicit times of the fundamental component were analyzed. "Supernormal flicker ERGs" were defined as those whose amplitudes were ≥117% of the unaffected fellow eyes. Results Ten of the 48 eyes (20.8%) with a CRVO showed supernormal flicker ERGs before the treatment. The difference in the implicit times of these 10 CRVO eyes and those of normal fellow eyes was
- Published
- 2018